IUPAC NAME-1-hydrazinylphthalazine
MOLECULAR FORMULA-C8H8N4
MOLAR MASS-160.176 g/mol
Hydralazine is not used as a primary drug for treating hypertension because it elicits a reflex sympathetic stimulation of the heart (the baroreceptor reflex). The sympathetic stimulation may increase heart rate and cardiac output, and in patients with coronary artery disease may cause angina pectoris or myocardial infarction.
SWAPNROOP DRUGS & PHARMACEUTICALS is a high tech enterprise which engaged in Loan Licensing Manufacturing of Pharmaceutical Formulation such as Tablets, Capsules, Liquid and semisolid Preparations and marketing of Quality Products in Domestic. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti-malarial, cardiology, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. Also deals with trading o...
View more >>
Basic Information
Business Type: Manufacturer,Trading Company,Distributor/Wholesaler
Product/Service (We Buy): 11 - 50 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$501 Thousand - US$1 Million
Year Established: 2000
Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 4
Number of R&D Staff: 97
Total Annual Sales Volume: US$2.5 Million - US$5 Million
India
